Abstract | PURPOSE OF REVIEW: RECENT FINDINGS: SUMMARY: Several issues remain open, such as optimal dose, optimal timing with respect to infusion of stem cells and whether the commercially available agents have comparable effects. Prospective trials are needed to answer these important questions.
|
Authors | Andrea Bacigalupo |
Journal | Current opinion in hematology
(Curr Opin Hematol)
Vol. 12
Issue 6
Pg. 457-62
(Nov 2005)
ISSN: 1065-6251 [Print] United States |
PMID | 16217162
(Publication Type: Journal Article, Review)
|
Chemical References |
|
Topics |
- Antilymphocyte Serum
(therapeutic use)
- Graft vs Host Disease
(prevention & control)
- Hematopoietic Stem Cell Transplantation
(adverse effects)
- Humans
- Leukemia, Myeloid, Acute
(therapy)
- Randomized Controlled Trials as Topic
- Retrospective Studies
- T-Lymphocytes
(immunology)
|